Les effets secondaires des antiglaucomateuxEHONGO, A; BREMER, F.Bulletin de la Société belge d'ophtalmologie. 2007, Num 304, pp 103-110, issn 0081-0746, 8 p.Article

Spanish multicenter tafluprost tolerability studyMILLA, Elena; STIRBU, Oana; REY, Amanda et al.British journal of ophthalmology. 2012, Vol 96, Num 6, pp 826-831, issn 0007-1161, 6 p.Article

Diacetyl nadolol: 3-month ocular hypotensive effect in glaucomatous eyesDUZMAN, E; ROSEN, N; LAZAR, M et al.British journal of ophthalmology. 1983, Vol 67, Num 10, pp 668-673, issn 0007-1161Article

Effects of antiglaucoma drops on MMP and TIMP balance in conjunctival and subconjunctival tissueITO, Tadashi; OHGURO, Hiroshi; MAMIYA, Kazuhisa et al.Investigative ophthalmology & visual science. 2006, Vol 47, Num 3, pp 823-830, issn 0146-0404, 8 p.Article

The pharmacology of antiglaucoma drugsSUGRUE, M. F.Pharmacology & therapeutics (Oxford). 1989, Vol 43, Num 1, pp 91-138, issn 0163-7258Article

Adoption of New Antiglaucoma Drugs in Finland : Impact of Changes in CopaymentMARTIKAINEN, Jaana E; HÄKKINEN, Unto; ENLUND, Hannes et al.Clinical therapeutics. 2007, Vol 29, Num 11, pp 2468-2476, issn 0149-2918, 9 p.Article

Bimatoprost: A novel antiglaucoma agentWOODWARD, D. F; PHELPS, R. L; KRAUSS, A. H-P et al.Cardiovascular drug reviews (Print). 2004, Vol 22, Num 2, pp 103-120, issn 0897-5957, 18 p.Article

EFFETS CYTOTOXIQUES D'ANTIGLAUCOMATEUX EN CULTURES DE CELLULES CONJONCTIVALES HUMAINESTAKAHASHI N.1981; NIHON GANKA GAKKAI ZASSHI; ISSN 0029-0203; JPN; DA. 1981; VOL. 85; NO 8; PP. 204-209; ABS. ENG; BIBL. 16 REF.Article

Pathologies iatrogènes liées aux traitements du glaucome = Side effects of glaucoma treatmentsBRON, A.Journal français d'ophtalmologie. 2009, Vol 32, Num 1, pp 71-78, issn 0181-5512, 8 p.Article

Corneal sensitivity changes following the instillation of latanoprost, bimatoprost, and travoprost eyedropsKOZOBOLIS, Vassilios P; DETORAKIS, Efstathios T; MASKALERIS, George et al.American journal of ophthalmology. 2005, Vol 139, Num 4, pp 742-743, issn 0002-9394, 2 p.Article

Update on the use of prostaglandin analogs in glaucoma therapyCAMRAS, Carl B; TORIS, Carol B; ALM, Albert et al.Survey of ophthalmology. 2002, Vol 47, issn 0039-6257, 239 p., SUP1Serial Issue

Effects of AGN 192024, a new Ocular Hypotensive agent, on aqueous dynamicsBRUBAKER, Richard F; SCHOFF, Erik O; NAU, Cherie B et al.American journal of ophthalmology. 2001, Vol 131, Num 1, pp 19-24, issn 0002-9394Article

Bétagan collyre (lévobunolol) = Betagan eye drop (levobunolol)La Revue Prescrire. 1995, Vol 15, Num 152, pp 414-415, issn 0247-7750Article

Differential pulse polarographic assay of timolol maleateALVAREZ-LUEJE; NUNEZ-VERGARA, L. J; SQUELLA, J. A et al.Farmaco (Il) : (1989). 1991, Vol 46, Num 4, pp 593-600, 8 p.Article

On cardiovascular effects of topical glaucoma therapy [2(2&3):99, 1983]. ReplyNOVACK, G. D; MCDONALD, T. O; DE SOUSA, B et al.Journal of toxicology. Cutaneous and ocular toxicology. 1984, Vol 3, Num 3, pp 243-250, issn 0731-3829Article

Topical Timolol for a Refractory WoundTANG, Jennifer C; DOSAL, Jacquelyn; KIRSNER, Robert S et al.Dermatologic surgery. 2012, Vol 38, Num 1, pp 135-138, issn 1076-0512, 4 p.Article

Severe darkening of a facial skin graft from latanoprostCALLADINE, Daniel; HARRISON, Rosalind J.Archives of ophthalmology (1960). 2007, Vol 125, Num 10, pp 1427-1428, issn 0003-9950, 2 p.Article

Analysis of irises with a latanoprost-induced change in Iris colorARRANZ-MARQUEZ, Esther; TEUS, Miguel A; SAORNIL, M. Antonia et al.American journal of ophthalmology. 2004, Vol 138, Num 4, pp 625-630, issn 0002-9394, 6 p.Article

Treatment of glaucoma using minidrops of clonidinePETURSSON, G; COLE, R; HANNA, C et al.Archives of ophthalmology (1960). 1984, Vol 102, Num 8, pp 1180-1181, issn 0003-9950Article

ADDITION OF PINDOLOL TO ROUTINE MEDICAL THERAPY: A CLINICAL TRIALSMITH RJH; BLAMIRES T; NAGASUBRAMANIAN S et al.1982; BR. J. OPHTHALMOL.; ISSN 0007-1161; GBR; DA. 1982; VOL. 66; NO 2; PP. 102-108; BIBL. 3 REF.Article

TRADITIONAL ANTIGLAUCOMA THERAPY: A CLINICAL SURVEY OF SIDE EFFECTSSTAFFORD WR.1981; CURR. THER. RES.; ISSN 0011-393X; USA; DA. 1981; VOL. 29; NO 2; PP. 265-274; BIBL. 8 REF.Article

STUDIES OF ACTION MECHANISM OF ANTIGLAUCOMA DRUGS WITH A NEWLY DEVELOPED CAT MODELCHIOU GCY; LIU HK; TRZECIAKOWSKI J et al.1980; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1980; VOL. 27; NO 25-26; PP. 2445-2451; BIBL. 33 REF.Article

LES ANTIGLAUCOMATEUX: DES MEDICAMENTS EFFICACES DONT LE MECANISME D'ACTION EST MAL CONNURENAUD B.1980; LYON PHARM.; ISSN 0024-7804; FRA; DA. 1980; VOL. 31; NO 5; PP. 301-302Article

Eyelash Growth from Application of Bimatoprost in Gel Suspension to the Base of the EyelashesWESTER, Sara Tullis; LEE, Wendy W; WEI SHI et al.Ophthalmology (Rochester, MN). 2010, Vol 117, Num 5, pp 1024-1031, issn 0161-6420, 8 p.Article

Dorzolamide-induced choroidal detachment in a surgically untreated eyeGOLDBERG, Sharon; GALLILY, Ruth; BISHARA, Salim et al.American journal of ophthalmology. 2004, Vol 138, Num 2, pp 285-286, issn 0002-9394, 2 p.Article